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Abstract
Background and aims: Colorectal cancer (CRC) is the third most common cancer, worldwide. Recently, much
attention has been given to the association between Dietary Approaches to Stop Hypertension (DASH) and CRC,
however, data on colorectal adenomas (CRAs) as its precursor are scarce. Thus, the purpose of this case-control
study was to investigate the association of DASH score with the risk of CRC and CRA in Iranian adults.
Method: A total of 499 participants, including 129 CRC and 130 CRA cases, along with 240 controls, were asked
about their dietary intake via a validated questionnaire. The DASH score was then calculated based on a priori
methods and categorized in quartiles. Multivariate logistic regression was performed to assess the association of
DASH score and the risk of CRC and CRA.
Results: After adjusting for confounding variables, adherence to the DASH diet was associated with a reduction in
the risk of CRC and CRA, respectively (OR of 4th versus 1st quartile = 0.04, 95% CI: 0.01–0.11, OR = 0.10, 95% CI: 0.04–
0.22). Also, subgroup analysis based on gender showed that women and men with a higher DASH score had a
significantly lower risk of CRC and CRAs.
Conclusion: The results of this study demonstrated that adherence to a DASH dietary pattern could reduce the risk
of CRC and CRA in men and women. Promoting a DASH eating plan can be helpful in reducing the risk of CRC.
Keywords: Colorectal cancer, Colorectal adenomas, Adenomatous polyps, Dietary approaches to stop hypertension,
DASH score, Dietary indexes, Diet quality indexes
Background
Colorectal cancer (CRC) is the third most common can-
cer worldwide, and was recently estimated to be respon-
sible for 694,000 deaths globally [1]. The distribution of
CRC incidence varies by country, with the highest rates
in well developed countries [2]. However, recent lifestyle
changes in less developed countries have elicited a rapid
rise of CRC incidence in these countries. Indeed, CRC is
the fourth most common cancer in Iran and its’ inci-
dence has been increasing during the past decade [3].
Inflammatory bowel disease, age, smoking, physical ac-
tivity, obesity, and diet are well known risk factors of
CRC [4, 5]. Also, the vast majority of CRCs arise from
colorectal adenomas (CRAs); these are benign lesions
that take approximately 10 years to become cancerous
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and people with history of adenomas are at an increased
risk of CRC [6].
Among modifiable risk factors of CRC, diet has gained
much attention [7]; indeed, with the goal of reducing
disease risk and preventing chronic disease, including
cancers, several dietary recommendations and patterns
have been advocated [8, 9]. Moreover, various scoring
systems, such as Healthy Eating Index, Dietary Ap-
proaches to Stop Hypertension (DASH), and Mediterra-
nean Style Dietary Pattern Score have been used to
evaluate the adherence of populations to those dietary
recommendations [10–12].
DASH is a dietary pattern, rich in fruits, vegetables,
nuts, seeds, whole grain cereals, moderate in low-fat
dairies, and low in sodium and added sugars. It was ini-
tially developed for management of high blood pressure
[13, 14]; yet, in addition to blood pressure, some studies
have shown an association between the DASH dietary
pattern and lower incidence of other chronic disease,
such as cancers [15, 16]. Although several, individual,
components of DASH dietary pattern are associated with
a reduced risk of CRC (whole grains, dairy product and
lower amount of red meat, sodium and extra sugar) and
CRA (red meat and extra carbohydrate), this association
has not been affirmed for all components of this dietary
pattern [17–21]. Accordingly, rather than concentrating
on single foods and nutrients, utilization of the whole
DASH plan in investigating diet-CRA- CRC relations
can be beneficial [14]. Indeed, some studies have re-
ported an inverse association between adherence to the
DASH pattern and CRC [22, 23], and two studies have
shown this association with CRA [24, 25].
Previous studies have principally focused on CRC,
however, data pertaining to CRA are sparse. Also, to the
best of our knowledge, data about the relationship be-
tween DASH pattern adherence and CRC and CRA are
predominantly confined to western countries, with scant
evidence from less developed countries, such as Iran.
Therefore, the objective of this study was to determine
whether DASH dietary pattern adherence is associated
with CRC and CRA, as a precursor of CRC, in a case-
control study of Iranian adults.
Method
Study design and population
This hospital-based case-control study was conducted in
3 major referral hospital (Taleghani, Shohadae Tajrish
and Emam Hosein). The study participants had already
been recruited for another study [26]. Briefly, CRC and
CRA cases were patients with colonoscopy and histologi-
cally confirmed CRC and CRA, aged 30–79, with no his-
tory of cancers, polyps and inflammatory bowel diseases
(IBD), and diagnosed in the preceding 3 months before
the interview. Over the same period of time, controls
were assigned randomly from patients admitted to the
same hospitals for a wide spectrum of diseases other
than cancers and polyps and IBD and did not follow any
special diet. Controls were frequency-matched with
cases by sex and age (10-year groups) and they were
aged 30-79y. After exclusion of subjects with incomplete
food frequency questionnaire (FFQ) and implausible en-
ergy intake estimates (outside the range of ±3 standard
deviation from the mean), 499 participants (240 controls,
129 CRC and 130 CRAs) were included in the analysis.
Informed consent was provided by all of the participants.
Study protocol was approved by the ethics Committee of
Shahid Beheshti University of Medical Sciences.
Dietary assessment
In this study, usual dietary intake of participants one
year before diagnosis of diseases in cases, and one year
prior to interview in controls was assessed through a
valid and reliable semi-quantitative food frequency ques-
tionnaire, consisting of 148 foods and beverages [27].
For each item, participant were asked to specify how
often (daily, weekly and monthly) they consumed foods
based on a standard serving size. Then reported intakes
were converted to weight equivalent (i.e. g, mg) per day.
Energy and nutrients intake were estimated using United
States Department of Agriculture (USDA) food compos-
ition table. However, for some traditional Iranian foods,
such as traditional bread, the Iranian food composition
table was used [28].
Calculation of DASH score
The method introduced by Fung [29] was used to meas-
ure dietary DASH score. Initially, to undo the effect of
individual energy intake on the components of the
DASH score, each food group intake was calculated per
1000 kcal. Then, participants were classified into quin-
tiles and energy adjusted intake of 8 food groups and
nutrients including fruits, vegetables, nuts and seeds and
legumes, low-fat dairy products, whole grains which are
targeted in the DASH score (adequacy components) and
sodium, sweetened beverages, and red and processed
meat which are minimized in DASH score (moderation
components), were calculated. Individuals in highest
quintiles of 5 adequacy components received 5 points
and those in the lowest quintiles received minimum
score of 1. Regarding the intakes of moderation compo-
nents, participants in the lower quintiles of intakes
scored higher points (i.e., the lowest quintiles are
assigned 5 points and the highest quintiles, 1 point).
Finally. The total DASH score (ranged from 8 to 40) was
provided by summing up the scores of 8 components for
each individual.
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Covariates’ assessment
In addition to dietary assessment, necessary information
about sociodemographic, characteristics, family history
of CRC and other cancers, smoking habit, medical his-
tory (comorbidities, medications, and vitamin/mineral
supplements intake), and usual cooking techniques were
asked in a face-to-face interview. Height and weight
were measured to the closest 0.1 cm and 100 g, respect-
ively. Furthermore, physical activity was assessed by a
validated questionnaire [30].
Statistical analysis
SPSS version 21.0 (SPSS Inc., Chicago, IL, 113 USA) was
used to conduct Statistical analyses. Data were analyzed
for normality using the Kolmogorov-Smirnov test, and
are showed as means ± SD (for normally distributed
data) or median and interquartile range (for non-
normally distributed data). The differences between par-
ticipants across the quartiles of energy-adjusted DASH
score were compared using analysis of variance
(ANOVA) or Kruskal-Wallis test (Kruskal-Wallis test
used for non-normally distributed data) and the chi-
square tests for quantitative variables and qualitative var-
iables, respectively. Dietary DASH score was categorized
into 4 quartiles based on the distribution among con-
trols. Binary logistic regression was applied to estimate
odds ratios (ORs) and 95% confidence intervals for quar-
tiles of DASH score. BMI (kg/m2), age (year), alcohol
consumption, physical activity (MET), and history of
diabetes, Coronary heart disease (CHD) and hyperten-
sion, family history of cancer were considered as poten-
tial confounders and were included in the models. The
p-value of < 0.05 was considered statistically significant
and all reported p-values are two-tailed.
Results
Table 1 demonstrates the main characteristic of cases
and controls. There was no statistically significant differ-
ence among participants (cancers and controls, aden-
omas and controls) in relation to BMI, family history of
colorectal cancer in first-degree relatives, smoking sta-
tus, vitamin D supplement, multivitamin use and energy
intake. However, family history of cancer in first-degree
relatives of CRC cases was higher than controls (51.2%
versus 32.9%; p-value< 0.01). Compared to controls, hav-
ing at least one comorbidity such as diabetes was seen
more in adenoma cases (36.9% versus 15.8%; p-value<
0.01) and the calcium supplement consumption was
higher in adenoma cases than controls (24.6% versus
14.6; p-value = 0.01). Besides, the median value for phys-
ical activity was significantly higher in controls than ad-
enomas [39.02 (36.51–41.33) vs. 37.75(34.67–40.40); p-
value< 0.01]. Controls had lower intake of salt compared
to CRC and CRA cases (p-value = 0.002). Common ways
of cooking among controls differed significantly from
cancer and adenomas patients, (p-value< 0.05). In details,
cancer cases consumed more grilled and fried foods
compare to controls and steamed food was consumed
lower in adenomas than in controls.
Table 2 shows the distribution of participants in
DASH score quartiles, according to main characteristics.
Participants in the highest DASH quartile had lower so-
dium intake (p < 0.001) and were older (58.19 vs 54.29y,
p = 0.002) compared to the lowest quartile.
Energy-adjusted DASH score and DASH score compo-
nents are shown in Table 3. Compared to control group,
patients with CRC and CRAs had significantly lower
DASH score (21, 22 vs 27, p < 0.001). Patients in both
CRA and CRC groups ate less servings of vegetables,
fruits, whole grains and nuts, legumes, and seeds than
the control group (p < 0.01). The consumption of so-
dium, red and processed meats, and sweetened bever-
ages were significantly higher in CRC and CRA groups
compared to the control group.
Crude and multi-variable adjusted ORs and 95% confi-
dence interval for risk of CRC and CRA, based on quar-
tile of energy-adjusted DASH score, are provided in
Table 4. We found that patients in highest quartile of
DASH score had a significant reduction in the risk of
both CRC and CRA vs. the lowest quartile. After adjust-
ing for confounding variables, including BMI (kg/m2),
age (year), alcohol consumption, physical activity (MET),
history of diabetes, CHD and hypertension and family
history of cancer, adherence to the DASH diet was asso-
ciated with a reduction in the risk of CRC and CRA, re-
spectively (OR = 0.04, 95% CI: 0.01–0.11, OR = 0.10, 95%
CI: 0.04–0.22). Also, subgroup analysis based on gender
showed that both women and men with higher DASH
scores had significantly lower risk of CRC and CRAs.
Discussion
In this case-control study of Iranian men and women,
we observed that a higher DASH score was associated
with a reduced risk of CRC and CRAs in Iranian adults.
In addition, this association was seen in subgroup ana-
lysis based on gender, where a higher DASH score was
related to lower risk of both CRC and CRA in men and
women.
The findings of our study are in line with some other
studies that displayed an inverse relationship between
DASH score and the risk of CRC [22, 31] and CRAs [24,
25]. Indeed, considering studies that performed sex-
specific analysis, four studies showed a significant in-
verse association between higher DASH scores and CRC
risk only in men [31–33] and one study only in women
[34]. However, another study reported this relationship
was present only in women, where the authors noted a
reduced risk of CRC in higher quartiles of DASH score
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[35]. Indeed, disparities between studies could be due to
the following reasons: differences in etiology of CRC and
responses to diet in men and women, hormone replace-
ment therapy (HRT) and oral contraceptive (OCP) con-
sumption in women which are independently and
inversely associated to CRC risk [33, 36] and considering
colon and rectum cancer separately or as a single cancer
in analyses. Our study agrees with the result of a newly
published systematic review and meta-analysis which re-
ported an inverse significant association between higher
DASH scores and reduced risks of CRC in both genders
[21]. However, risk reduction in our study is far different
from previous studies. This difference could represent a
random variation, favored by the small sample size of
some studies, or could be due to adjustment for different
confounders, using self-administered FFQs in some of
studies which are prone to self-report bias, whereas we
administered face-to face interview by trained
interviewers.
The DASH dietary pattern emphasizes the consump-
tion of plant foods. Phytochemical and other antioxi-
dants in these foods exert their anti-tumorigenic
characteristics via inhibition of CRC cell growth (sup-
pression of NF-κB pathway), inducing apoptosis, and re-
action with reactive oxygen species [37, 38]. Further,
they can interact with CRA and CRC cell growth by
blocking the natural cell cycle [39]. Fiber content of
plant foods is known to reduce the risk of CRC and
CRA by increasing fecal volume, decreasing transit time,
and therefore, decreasing the interaction of carcinogen
Table 1 The main characteristics of the cases and controls
Variables Controls (n = 240) Cancers (n = 129) Adenomas (n = 130) P-value£ P-value†
Age (years) 56 (50–61.75) 59 (49.25–64) 58 (51–64) ‡ ‡
Gender (male) 133 (55.4) 66 (51.2) 59 (45.4) ‡ ‡
BMI (kg/m2) 26.53 (24.10–29.40) 25.70 (23.08–29.74) 26.79 (23.86–29.40) 0.23 0.95
Smoking (yes) 42 (17.5) 26 (20.2) 27 (20.8) 0.53 0.11
Comorbidities (yes) ¥ 38 (15.8) 17 (13.2) 48 (36.9) 0.84 0.002**
Diabetes (yes) 20 (8.3) 12 (9.3) 12 (9.2) 0.75 0.77
Hypertension (yes) 13 (5.4) 4 (3.1) 23 (17.7) 0.34 0.01**
Coronary Heart diseases (yes) 5 (2.1) 1 (0.8) 13 (10.0) 0.31 0.00**
Family history of cancer in first
degree (yes)
89 (32.9) 66 (51.2) 48 (36.9) 0.001** 0.43
Colorectal cancer family history
in first degree relatives (yes)
18 (7.5) 10 (7.8) 17 (13.1) 0.15 0.08
Common ways of cooking food
Fried 55 (22.9) 40 (31) 18 (13.8) 0.001** 0.06
Boiled 81 (33.8) 41 (31.8) 34 (26.2) 0.75 0.82
Grilled 5 (2.1) 0 (0) 4 (3.1) 0.02** 0.52
Steam cook 3 (1.3) 2 (1.6) 0 (0) 0.32 0.006**
Combined 96 (40) 46 (35.7) 74 (56.9) 0.001** 0.06
Level of salt intake
Low 127 (52.9) 44 (34.1) 44 (34.1) 0.002** 0.002**
Normal 79 (32.9) 64 (49.6) 64 (49.6) 0.08 0.08
High 34 (14.2) 21 (16.3) 21 (16.3) 0.07 0.07
Physical activity (MET/h/day) 39.02 (36.51–41.33) 39.30 (37.17–40.90) 37.75 (34.67–40.40) 0.85 0.003*
Monthly intake of 50,000 IU Vitamin
D supplement (yes)
56 (23.3) 28 (21.7) 40 (30.8) 0.72 0.11
Daily intake of 500 mg Calcium
supplement (yes)
35 (14.6) 28 (21.7) 32 (24.6) 0.08 0.01**
Multivitamin use every day (yes) 18 (7.5) 16 (12.4) 9 (7) 0.12 0.84
Energy intake (kJ/day) 9549.06 (8122.15–11,140.99) 9154.93 (7714.92–11,087.06) 9221.62 (7648.02–11,608.63) 0.35 0.35
‡Matched variables of the study, £p-value between cancers and controls, †p-value between adenomas and controls
Values are presented as median (Q1-Q3) for quantitative variables or n (%) for qualitative variables
* Significant difference (Mann-Whitney U, p-value < 0.05) ** Significant difference (Chi-Square, p-value < 0.05)
¥ Comorbidities are defined as diabetes, hypertension and coronary heart disease
MET Metabolic equivalent
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Table 2 The main characteristics of the participants according to quartiles of energy-adjusted DASH score
Variables DASH score quartiles P-value*
Quartile 1 Quartile 2 Quartile 3 Quartile 4
< 20 21–24 25–28 > 29
Age (years)‡ 54.29(11.76) 54.19(9.72) 57.19(9.44) 58.19(8.56) 0.002
Gender ‡
Woman 58(41.7) 66(50.4) 62(51.2) 55(50.9) 0.34
Man 81(58.3) 65(49.6) 59(48.8) 53(49.1)
BMI (kg/m2) 26.71(4.04) 26.91(5.21) 26.61(4.36) 27.04(3.69) 0.87
Energy intake (kcal) 2341.1(678.5) 2357.1(681.8) 2299.1(659.7) 2299.7(552.5) 0.85
Physical activity (MET/day) 36.82(7.78) 38.62(14.85) 39.86(11.75) 40.24(9.8) 0.07
Education levels
Illiterate 20(14.6) 20(15.5) 17(14) 6(5.6) 0.21
Low 99(72.3) 91(70.5) 87(71.9) 80(74.1)
High 18(13.1) 18(14) 17(14) 22(20.4)
Smoking (yes) 35(25.2) 21(16) 21(17.4) 18(16.7) 0.32
Comorbidities (yes) ¥ 27(19.4) 24(18.3) 31(25.6) 20(18.5) 0.44
Diabetes (yes) 10(7.2) 10(7.6) 13(10.7) 11(10.2) 0.68
Hypertension (yes) 12(8.6) 9(6.9) 13(10.7) 6(5.6) 0.49
Coronary Heart diseases (yes) 5(3.6) 3(2.3) 7(5.8) 4(3.7) 0.54
Family history of cancer in first degree (yes) 62(44.6) 50(38.2) 37(30.6) 44(40.7) 0.13
Colorectal cancer family history in first degree
relatives (yes)
13(9.4) 12(9.2) 9(7.4) 11(10.2) 0.87
Level of salt intake
Low 40(28.8) 58(44.3) 62(51.2) 69(63.9)
Normal 70(50.4) 51(38.9) 49(40.5) 32(29.6) 0.00
High 29(20.9) 22(16.8) 10(8.6) 7(6.5)
Alcohol consumption 11(7.9) 4(3.1) 4(3.3) 4(3.7) 0.11
Daily intake of multi vitamins and minerals (yes) 8(5.8) 15(11.5) 7(5.8) 13(12) 0.13
Values are mean (SD) or number (percentage)
‡Matched variables of the study, *p-value between quartiles of DASH score
Independent sample t-test was used for continuous variables and Chi-square was used for categorical variables. MET: Metabolic equivalent
¥ Comorbidities are defined as diabetes, hypertension and coronary heart disease
Table 3 A comparison between the case (Cancer and adenomas) and control groups based on daily intake of the energy-adjusted
DASH score components
DASH score components control Colorectal cancer Adenomas p-value*
(n = 240) (n = 129) (n = 130)
Energy-adjusted DASH score 27(23–30) 21(19–24) 22(19.7–26) < 0.001
Vegetables (serving/1000 kcal) 1.67(0.84) 1.20(0.49) 1.46(0.82) < 0.001
Fruits (serving/1000 kcal) 1.12(0.50) 0.79(0.32) 0.98(0.45) < 0.001
Whole grains (serving/1000 kcal) 1.43(1.16) 1.09(0.81) 1.27(1.05) 0.01
Nuts, legumes and seeds (serving/1000 kcal) 0.55(0.38) 0.47(0.32) 0.50(0.38) 0.09
Low fat dairy (serving/1000 kcal) 0.73(0.44) 0.75(0.47) 0.75(0.44) 0.91
Red and processed meats (serving/1000 kcal) 0.29(0.20) 0.59(0.39) 0.47(0.30) < 0.001
Sweetened beverages (serving/1000 kcal) 0.06(0.12) 0.08(0.12) 0.10(0.15) 0.01
Sodium (g/d) 1857.1(512.5) 2155.69(579.1) 2149.2(587.6) < 0.001
Values are mean (SD) or median (IQR)
* P-value estimated using ANOVA or Kruskal-wllis test
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Table 4 OR and 95% confidence interval for risk of colorectal cancer, adenoma and colorectal cancer plus adenoma based on
quartile of energy-adjusted DASH score











Case (control) 19(14) 23(23) 16(28) 5(42)
Crude OR (95% CI) 1.00 0.73(0.29–1.81) 0.42(0.16–1.06) 0.08(0.02–0.27) < 0.001
Adjusted OR* (95% CI) 1.00 0.76(0.29–1.97) 0.42(0.16–1.11) 0.07(0.02–0.24) < 0.001
Adjusted OR**(95% CI) 1.00 0.89(0.31–2.54) 0.42(0.14–1.24) 0.07(0.02–0.26) < 0.001
Men
Case (control) 37(22) 22(26) 5(40) 2(45)
Crude OR (95% CI) 1.00 0.50(0.23–1.09) 0.07(0.02–0.21) 0.02(0.00–0.12) < 0.001
Adjusted OR* (95% CI) 1.00 0.47(0.21–1.06) 0.06(0.02–0.18) 0.02(0.00–0.10) < 0.001
Adjusted OR**(95% CI) 1.00 0.63(0.26–1.48) 0.07(0.02–0.24) 0.02(0.00–0.13) < 0.001
Pooled
Case (control) 56(36) 45(49) 21(68) 7(87)
Crude OR (95% CI) 1.00 0.59(0.33–1.05) 0.19 (0.10–0.37) 0.05(0.02–0.12) < 0.001
Adjusted OR* (95% CI) 1.00 0.57(0.31–1.04) 0.17(0.09–0.34) 0.04 (0.01–0.10) < 0.001
Adjusted OR**(95% CI) 1.00 0.69(0.36–1.31) 0.22(0.11–0.44) 0.04(0.01–0.11) < 0.001
Adenoma
Women
Case (control) 25(14) 20(23) 18(28) 8(42)
Crude OR (95% CI) 1.00 0.58(0.28–1.21) 0.38(0.18–0.79) 0.13(0.05–0.32) < 0.001
Adjusted OR* (95% CI) 1.00 0.57(0.27–1.19) 0.32 (0.15–0.68) 0.04(0.04–0.27) < 0.001
Adjusted OR**(95% CI) 1.00 0.42(0.16–1.12) 0.25(0.09–0.69) 0.06 (0.02–0.20) < 0.001
Men
Case (control) 22(22) 17(26) 14(40) 6(45)
Crude OR (95% CI) 1.00 0.56(0.26–1.22) 0.33(0.15–0.73) 0.11(0.04–0.30) < 0.001
Adjusted OR* (95% CI) 1.00 0.65(0.27–1.53) 0.35(0.15–0.81) 0.13(0.04–0.37) < 0.001
Adjusted OR**(95% CI) 1.00 0.68(0.26–1.72) 0.30 (0.11–0.80) 0.14(0.04–0.44) < 0.001
Pooled
Case (control) 47(36) 37(49) 32(68) 14(87)
Crude OR (95% CI) 1.00 0.57(0.37–1.06) 0.36(0.19–0.66) 0.12 (0.06–0.25) < 0.001
Adjusted OR* (95% CI) 1.00 0.57(0.31–1.07) 0.30 (0.16–0.57) 0.10(0.04–0.21) < 0.001
Adjusted OR**(95% CI) 1.00 0.60(0.31–1.15) 0.31 (0.16–0.61) 0.10(0.04–0.22) < 0.001
Colorectal cancer plus Adenoma
Women
Case (control) 44(14) 43(23) 34(28) 13(42) < 0.001
Crude OR (95% CI) 1.00 0.59(0.27–1.30) 0.38(0.17–0.84) 0.09(0.04–0.23) < 0.001
Adjusted OR* (95% CI) 1.00 0.55(0.24–1.24) 0.34(0.15–0.77) 0.08(0.03–0.20) < 0.001
Adjusted OR**(95% CI) 1.00 0.59(0.25–1.39) 0.35(0.15–0.83) 0.07 (0.02–0.18)
Men
Case (control) 59(22) 39(26) 19(40) 8(45) < 0.001
Crude OR (95% CI) 1.00 0.55(0.27–1.12) 0.17(0.08–0.36) 0.06(0.02–0.16) 0.03
Adjusted OR* (95% CI) 1.00 0.55(0.27–1.12) 0.15(0.07–0.33) 0.05(0.02–0.14) < 0.001
Adjusted OR**(95% CI) 1.00 0.64(0.30–1.35) 0.16 (0.07–0.37) 0.06(0.02–0.16)
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with colonic epithelium, production of short chain fatty
acids, and insulin resistance [40, 41]. The DASH dietary
pattern is also low in red and processed meat; indeed,
the high fat content of red meat, and heterocyclic
amines and polycyclic aromatic hydrocarbons produced
from cocking meat at high temperatures, in addition to
nitrosyl-heme molecules in processed meats that result
in N-nitroso compounds formation, are associated with
increased risk of CRC and CRA [42, 43]. The DASH
diet also advocates lower intakes of sugar-sweetened
beverages; although the relationship between such bever-
ages and CRC and CRA has not been fully confirmed,
hyperinsulinemia and increased insulin growth factor-1
(IGF-1) consequential to consumption of these drinks
can effect on carcinogenesis and conversion of aden-
omas to malignancies through crucial pathways, such as
mitogen-activated protein kinase (MAPK) pathway and
phosphoinositide 3-kinase (PI3K) pathway [44–46]. An
important feature of the DASH diet is low sodium in-
take; accordingly, results of studies on the association of
sodium and higher risk of CRC are not particularly
strong, but some studies have reported positive associa-
tions between sodium and CRC risk [47]. Indeed, con-
sidering the synergic interaction between components of
the DASH dietary pattern and CRC and CRA, rather
than individual components, can be helpful in providing
public messages to reduce the risk of CRC, and CRA as
a precursor of CRC.
Although this study presents an important and novel
addition to the literature, there are some limitations that
should be considered. First, recall and selection bias can-
not be avoided in case-control studies; however, we
sought to minimize such biases by recruiting incident
cases along with hospital controls. Second, we did not
have information about HRT and OCP use in women,
so the results could be affected by them, and they should
be considered as potentially confounding variables in fu-
ture work. Another limitation of our study is that al-
though sample size is not low, when we classified
participants according to various factors, the number of
people decreased in each quartile. Concomitant to the
aforementioned limitations, our study has some
strengths that are noteworthy. First, to our knowledge,
this is the first study on the association of DASH diet
score and the risk of CRC and CRA in Iran, and in the
Middle East. Second, we used Fung’s method to calcu-
late DASH score, which includes wider ranges of pos-
sible scores (1 through 5), while some scores, such as
Dixon’s, have only two values for components (0 for not
meeting and 1 for meeting recommendations) [23].
Third, we used a validated FFQ, administered by trained
nutritionists, to more accurately estimate the main
exposure [27].
Conclusion
In conclusion, the results of this study demonstrated
that adherence to a DASH dietary pattern could reduce
the risk of colorectal cancer and colorectal adenomas in
men and women. Moreover, promoting a DASH eating
plan, as a balanced and healthy diet, in dietary guidelines
could be helpful in reducing the risk of CRC in less-
developed countries.
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